Zobrazeno 1 - 10
of 17
pro vyhledávání: '"C L, Shapiro"'
Autor:
P M Mauch, C L Shapiro
Publikováno v:
Journal of Clinical Oncology. 10:1662-1665
Publikováno v:
Cancer. 91(1)
To gain insight into the factors that contribute to the more favorable prognosis associated with recurrence limited to bone in patients with breast carcinoma, the authors analyzed the number of sites of initial involvement identified on radionuclide
Publikováno v:
Cancer investigation. 17(8)
Response to systemic therapy in breast cancer patients with lytic skeletal metastases manifests as a shift from increased bone resorption to new bone formation. We hypothesized that dual-energy x-ray absorptiometry (DXA) could be used to prospectivel
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 17(5)
To estimate the toxicity and response rate of high-dose liposome-encapsulated doxorubicin (TLC D-99, Evacet, The Liposome Company Inc, Princeton, NJ) in patients with advanced breast cancer.Fifty-two breast cancer patients with bidimensionally measur
Autor:
B L, Samuels, D R, Hollis, G L, Rosner, D L, Trump, C L, Shapiro, N J, Vogelzang, R L, Schilsky
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(11)
Multidrug resistance mediated by P-glycoprotein may be an important cause of chemotherapy failure. Renal cell carcinoma is a disease known to demonstrate a high degree of intrinsic chemotherapy drug resistance, and this has been shown to be related t
Publikováno v:
Cancer. 83(2)
In response to the importance of early stage breast carcinoma as a public health concern and to the complexity of the clinical literature devoted to treatment of the disease, the National Institutes of Health has held a series of Consensus Developmen
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 1(8)
Pentoxifylline potentiates the cytotoxicity of alkylating agents in preclinical models. In this study we sought to define the maximum tolerated dose (MTD) of N,N',N"-triethylenethiophosphoramide (thioTEPA) with pentoxifylline, and to estimate the ant
Publikováno v:
Seminars in oncology. 22(2 Suppl 5)
Patients with recurrent breast cancer can be divided into three categories: those with locoregional recurrence, those with distant nonvisceral recurrence, and those with visceral recurrence. Survival from time of first relapse is clearly dependent on
Autor:
C L, Shapiro, I C, Henderson
Publikováno v:
Hematology/oncology clinics of North America. 8(1)
This article examines questions about adjuvant systemic therapy, especially in premenopausal and postmenopausal women. The impact of adjuvant therapy on quality of life is addressed, as is the role of doxorubicin in adjuvant chemotherapy. The value o
Autor:
C L, Shapiro
Publikováno v:
Hematology/oncology clinics of North America. 8(1)
The utility of bisphosphonates is well established in the treatment of acute hypercalcemia of malignancy. Bisphosphonates may also decrease the complications and morbidity of skeletal metastases. This article emphasizes the use of bisphosphonates in